ANNX
Price
$1.82
Change
-$0.13 (-6.63%)
Updated
Apr 3, 02:24 PM (EDT)
Capitalization
198.57M
46 days until earnings call
STOK
Price
$6.60
Change
+$0.37 (+5.94%)
Updated
Apr 2 closing price
Capitalization
356.91M
39 days until earnings call
Ad is loading...

ANNX vs STOK

Header iconANNX vs STOK Comparison
Open Charts ANNX vs STOKBanner chart's image
Annexon
Price$1.82
Change-$0.13 (-6.63%)
Volume$3.11K
Capitalization198.57M
Stoke Therapeutics
Price$6.60
Change+$0.37 (+5.94%)
Volume$795.56K
Capitalization356.91M
ANNX vs STOK Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. STOK commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and STOK is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ANNX: $1.96 vs. STOK: $6.60)
Brand notoriety: ANNX and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 206% vs. STOK: 93%
Market capitalization -- ANNX: $198.57M vs. STOK: $356.91M
ANNX [@Biotechnology] is valued at $198.57M. STOK’s [@Biotechnology] market capitalization is $356.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANNX and STOK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • ANNX’s TA Score: 4 bullish, 4 bearish.
  • STOK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ANNX and STOK are a good buy in the short-term.

Price Growth

ANNX (@Biotechnology) experienced а -14.22% price change this week, while STOK (@Biotechnology) price change was -10.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.55%. For the same industry, the average monthly price growth was -9.63%, and the average quarterly price growth was -13.98%.

Reported Earning Dates

ANNX is expected to report earnings on May 19, 2025.

STOK is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-7.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($357M) has a higher market cap than ANNX($199M). STOK YTD gains are higher at: -40.163 vs. ANNX (-61.793). STOK has higher annual earnings (EBITDA): -115.03M vs. ANNX (-151.48M). ANNX has more cash in the bank: 312M vs. STOK (239M). STOK has less debt than ANNX: STOK (2.3M) vs ANNX (29M). STOK has higher revenues than ANNX: STOK (16.7M) vs ANNX (0).
ANNXSTOKANNX / STOK
Capitalization199M357M56%
EBITDA-151.48M-115.03M132%
Gain YTD-61.793-40.163154%
P/E RatioN/AN/A-
Revenue016.7M-
Total Cash312M239M131%
Total Debt29M2.3M1,262%
TECHNICAL ANALYSIS
Technical Analysis
ANNXSTOK
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCMAX27.91N/A
N/A
Hillman Value No Load
MNNAX52.07N/A
N/A
Victory Munder Multi-Cap A
SXPAX45.91N/A
N/A
DWS S&P 500 Index A
WMGCX15.73N/A
N/A
Macquarie Mid Cap Growth C
FWRAX10.66N/A
N/A
Fidelity Advisor Global Real Estate A

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with AURA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+8.29%
AURA - ANNX
40%
Loosely correlated
+4.76%
FULC - ANNX
40%
Loosely correlated
+2.54%
IDYA - ANNX
38%
Loosely correlated
+10.70%
KYMR - ANNX
38%
Loosely correlated
+4.46%
STOK - ANNX
37%
Loosely correlated
+5.94%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with QTTB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+5.94%
QTTB - STOK
49%
Loosely correlated
-1.00%
RCKT - STOK
44%
Loosely correlated
+8.43%
DNLI - STOK
43%
Loosely correlated
+11.80%
NRIX - STOK
42%
Loosely correlated
+8.69%
LENZ - STOK
42%
Loosely correlated
-1.92%
More